Patrick Smith | Analyst | Ubika Research | Patrick@UbikaResearch.com | 1 (647) 444-5506
Maxim Medvedev | Associate | Ubika Research | | email@example.com | 1 (647) 936-6692
The Ubika Marijuana 25 Index of Canadian marijuana stocks continues to outperform year over year
Ubika Marijuana 25 Index May 11, 2018 - July 6, 2018
UMJ25 -1.5% (166.5% Y/Y)
TSX-V: -5.2% (-1.5% Y/Y)
HMMJ: 4.7% (116.8% Y/Y)
Dollar amounts in CAD unless otherwise stated.
Top Volume Gainers (30D/30D)
The Ubika Marijuana 25 Index has fallen slightly since our last report dated May 14, 2018, easing 1.5%. However, the index outperformed the TSXV Index, which fell by 5.2% over the same period. Notable performers in this report include:
- Canopy Growth Corporation (TSX:WEED), which surged 21% as Bill C-45 received Royal Assent. This appeared to solidify WEED dominant position in the market.
- Aurora Cannabis Inc. (TSX:ACB), which jumped 23% following numerous synergistic acquisitions and the upcoming completion of the MedReleaf acquisition.
This Content is Exclusive to Our Members
To read our full disclosure, please click on the button below: